Quebec News Tribune – Lifestyle
Author:
Laguna Biotherapeutics, Inc.
Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias
April 29, 2026
Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias
April 29, 2026